• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Laser in situ keratomileusis with the VISX Star laser for myopia over -10.0 diopters.

作者信息

Lyle W A, Jin G J

机构信息

The Eye Institute of Utah, Salt Lake City, Utah 84107, USA.

出版信息

J Cataract Refract Surg. 2001 Nov;27(11):1812-22. doi: 10.1016/s0886-3350(01)00968-3.

DOI:10.1016/s0886-3350(01)00968-3
PMID:11709256
Abstract

PURPOSE

To evaluate the efficacy, predictability, stability, and safety of laser in situ keratomileusis (LASIK) for myopia over -10.00 diopters (D).

SETTING

The Eye Institute of Utah, Salt Lake City, Utah, USA.

METHODS

The prospective study included 332 eyes of 183 patients having LASIK with the VISX Star laser to correct myopia of -10.00 to -18.00 D. The eyes were divided into 3 groups according to the preoperative refraction: Group A (n = 208), -10.00 to -11.90 D; Group B (n = 94), -12.00 to -14.00 D; Group C (n = 30), -14.10 to -18.00 D. The mean follow-up was 12.0 months +/- 5.6 (SD) (range 6 to 37 months).

RESULTS

Overall, the mean spherical equivalent decreased 96%, from -11.69 +/- 1.46 D preoperatively to -0.37 +/- 0.80 D postoperatively. The mean astigmatism decreased 72%, from 1.66 +/- 1.22 D to 0.46 +/- 0.53 D. At the last visit, 84.0% of eyes were within +/-1.00 D of emmetropia and 96.4% were within +/-2.00 D. An overcorrection of more than +1.00 D was experienced by 1.8% of patients. The uncorrected visual acuity (UCVA) was 20/20 or better in 45.8% of eyes and 20/40 or better in 89.5%. Six eyes (1.8%) lost 2 or more lines of best corrected visual acuity; this included 1 eye in which iatrogenic keratectasia developed 18 months after LASIK retreatment. Retreatment was done in 37.0% of eyes at a mean of 6.3 +/- 5.3 months (3 to 32 months) after the initial treatment. At the last examination, 86.0% of eyes in Groups A and B and 70.0% in Group C were within +/-1.00 D of emmetropia. A significant difference was found between Groups A and C (P =.032). The UCVA was 20/20 in 52.0% of Group A eyes, 38.0% of Group B eyes, and 23.0% of Group C eyes. The difference between Groups A and C was significant (P =.001), but the difference between Groups A and B was not (P =.055).

CONCLUSIONS

In this study, LASIK was effective in correcting myopia up to -14.00 D. The efficacy, predictability, and safety were significantly less in eyes with myopia greater than -14.00 D.

摘要

相似文献

1
Laser in situ keratomileusis with the VISX Star laser for myopia over -10.0 diopters.
J Cataract Refract Surg. 2001 Nov;27(11):1812-22. doi: 10.1016/s0886-3350(01)00968-3.
2
Laser in situ keratomileusis for consecutive hyperopia after myopic LASIK and radial keratotomy.准分子原位角膜磨镶术治疗近视性准分子原位角膜磨镶术和放射状角膜切开术后的连续远视。
J Cataract Refract Surg. 2003 May;29(5):879-88. doi: 10.1016/s0886-3350(03)00051-8.
3
Retreatment after initial laser in situ keratomileusis.
J Cataract Refract Surg. 2000 May;26(5):650-9. doi: 10.1016/s0886-3350(00)00319-9.
4
Laser in situ keratomileusis for residual myopia after photorefractive keratectomy.准分子激光原位角膜磨镶术治疗准分子激光角膜切削术后残余近视
J Cataract Refract Surg. 2002 May;28(5):775-81. doi: 10.1016/s0886-3350(02)01269-5.
5
CustomVue laser in situ keratomileusis for myopia and myopic astigmatism using the Visx S4 excimer laser: Efficacy, predictability, and safety.使用威视S4准分子激光的CustomVue准分子原位角膜磨镶术治疗近视和近视散光:疗效、可预测性及安全性。
J Cataract Refract Surg. 2006 Mar;32(3):475-9. doi: 10.1016/j.jcrs.2005.12.128.
6
Laser in situ keratomileusis for myopia up to -11 diopters with up to -5 diopters of astigmatism with the summit autonomous LADARVision excimer laser system.使用Summit Autonomous LADARVision准分子激光系统,对近视度数高达-11屈光度、散光度数高达-5屈光度的患者进行准分子原位角膜磨镶术。
Ophthalmology. 2001 Feb;108(2):309-16. doi: 10.1016/s0161-6420(00)00528-5.
7
Laser in situ keratomileusis enhancement for consecutive hyperopia after myopic overcorrection.准分子激光原位角膜磨镶术矫治近视过矫所致连续型远视
J Cataract Refract Surg. 2002 Jan;28(1):37-43. doi: 10.1016/s0886-3350(01)01120-8.
8
Laser in situ keratomileusis for the correction of residual ametropia after penetrating keratoplasty.准分子原位角膜磨镶术用于矫正穿透性角膜移植术后残余屈光不正。
J Cataract Refract Surg. 2004 May;30(5):1006-13. doi: 10.1016/j.jcrs.2003.08.035.
9
Laser in situ keratomileusis with a scanning excimer laser for the correction of low to moderate myopia with and without astigmatism.使用扫描准分子激光进行准分子原位角膜磨镶术,用于矫正伴有或不伴有散光的轻至中度近视。
J Cataract Refract Surg. 2001 Dec;27(12):1942-51. doi: 10.1016/s0886-3350(01)01017-3.
10
Hyperopic laser in situ keratomileusis: primary and secondary treatments are safe and effective.远视性准分子原位角膜磨镶术:初次和二次治疗均安全有效。
Cornea. 2001 May;20(4):388-93. doi: 10.1097/00003226-200105000-00010.

引用本文的文献

1
Investigation of the Changes in Refractive Surgery Trends in Korea.韩国屈光手术趋势变化的调查。
Korean J Ophthalmol. 2018 Feb;32(1):8-15. doi: 10.3341/kjo.2017.0010. Epub 2018 Jan 25.
2
Visual improvement in high myopic amblyopic adult eyes following phakic anterior chamber intraocular lens implantation.有晶状体眼后房型人工晶状体植入术后高度近视成人弱视眼的视力改善
Korean J Ophthalmol. 2006 Jun;20(2):87-92. doi: 10.3341/kjo.2006.20.2.87.